BioLineRx Ltd. - stock earnings
BLRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -16.0 million USD | ? USD |
| 2023Q2 | -18.5 million USD | ? USD |
| 2023Q1 | -15.5 million USD | ? USD |
| 2022Q4 | -3.1 million USD | ? USD |
| 2022Q3 | -6.6 million USD | ? USD |
| 2022Q2 | -7.3 million USD | ? USD |
| 2022Q1 | -3.8 million USD | ? USD |
| 2021Q4 | -2.0 million USD | ? USD |
| 2021Q3 | -5.7 million USD | ? USD |
| 2021Q2 | -6.8 million USD | ? USD |
| 2021Q1 | -10.2 million USD | ? USD |
| 2020Q4 | -12.0 million USD | ? USD |
| 2020Q3 | -4.6 million USD | ? USD |
| 2020Q2 | -6.8 million USD | ? USD |
| 2020Q1 | -6.6 million USD | ? USD |
| 2019Q4 | -9.9 million USD | ? USD |
| 2019Q3 | -3.9 million USD | ? USD |
| 2019Q2 | -5.5 million USD | ? USD |
| 2019Q1 | -6.2 million USD | ? USD |
| 2018Q4 | -5.7 million USD | ? USD |
| 2018Q3 | -6.3 million USD | ? USD |
| 2018Q2 | -4.8 million USD | ? USD |
| 2018Q1 | -6.2 million USD | ? USD |
| 2017Q4 | -7.4 million USD | ? USD |
| 2017Q3 | -7.2 million USD | ? USD |
| 2017Q2 | -4.9 million USD | ? USD |
| 2017Q1 | -4.9 million USD | ? USD |
| 2016Q4 | -4.3 million USD | ? USD |
| 2016Q3 | -4.3 million USD | ? USD |
| 2016Q2 | -3.7 million USD | ? USD |
| 2016Q1 | -3.5 million USD | ? USD |
| 2015Q4 | -3.7 million USD | ? USD |
| 2015Q3 | -1.6 million USD | ? USD |
| 2015Q2 | -4.8 million USD | ? USD |
| 2015Q1 | -4.3 million USD | ? USD |
| 2014Q4 | -3.7 million USD | ? USD |
| 2014Q3 | -680224 USD | ? USD |
| 2014Q2 | -4.1 million USD | ? USD |
| 2014Q1 | -2.1 million USD | ? USD |
| 2013Q4 | -4.7 million USD | 113.2 million USD |
| 2013Q3 | -5.0 million USD | ? USD |
| 2013Q2 | -4.3 million USD | ? USD |
| 2013Q1 | -3.5 million USD | ? USD |
| 2012Q4 | -7.3 million USD | 113.2 million USD |
| 2012Q3 | -5.7 million USD | ? USD |
| 2012Q2 | -2.9 million USD | ? USD |
| 2012Q1 | -4.8 million USD | ? USD |
| 2011Q4 | -3.6 million USD | 63.9 million USD |
| 2011Q3 | -2.1 million USD | ? USD |
| 2011Q2 | -4.8 million USD | ? USD |
| 2011Q1 | -3.3 million USD | ? USD |
| 2010Q4 | -6.0 million USD | 976081 USD |
| 2010Q3 | 20.0 million USD | 30.9 million USD |
| 2010Q2 | -7.3 million USD | ? USD |
| 2010Q1 | -4.2 million USD | ? USD |
| 2009Q4 | -16.2 million USD | 16.9 million USD |
BLRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -52.5 million USD | ? USD |
| 2022 | -18.9 million USD | ? USD |
| 2021 | -28.1 million USD | ? USD |
| 2020 | -30.9 million USD | ? USD |
| 2019 | -26.8 million USD | ? USD |
| 2018 | -18.5 million USD | ? USD |
| 2017 | -24.4 million USD | ? USD |
| 2016 | -15.8 million USD | ? USD |
| 2015 | -14.4 million USD | ? USD |
| 2014 | -10.2 million USD | ? USD |
| 2013 | -17.6 million USD | 113.2 million USD |
| 2012 | -20.4 million USD | 113.2 million USD |
| 2011 | -13.2 million USD | 63.9 million USD |
| 2010 | 2.1 million USD | 31.9 million USD |
BLRX
Price: $0.68
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.75 USD
P/E Ratio: -1.52
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 323100
Ebitda: -7.1 millionMarket Capitalization: 60.9 million